-
601
Elderly Patients with Mild Cognitive Impairment Exhibit Altered Gut Microbiota Profiles
Published 2021-01-01“…As a transitional state between normal aging and Alzheimer’s disease (AD), mild cognitive impairment (MCI) is characterized by a worse cognitive decline than that of natural aging. …”
Get full text
Article -
602
DFT Calculations and Molecular Docking Studies on a Chromene Derivative
Published 2021-01-01“…Finally, Chrom-D has been evaluated as a multifunctional agent against Alzheimer’s disease (AD).…”
Get full text
Article -
603
An Update on Inflamm-Aging: Mechanisms, Prevention, and Treatment
Published 2016-01-01“…Increasing evidence indicates that inflamm-aging is intensively associated with many aging diseases, such as Alzheimer’s disease, atherosclerosis, heart disease, type II diabetes, and cancer. …”
Get full text
Article -
604
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
Published 2025-02-01“…In this review, the research history and milestone events of studying metal ions, including iron, manganese, copper, and zinc in neurodegenerative diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD), will be introduced. …”
Get full text
Article -
605
Can Chaotic Analysis of Electroencephalogram Aid the Diagnosis of Encephalopathy?
Published 2018-01-01“…Chaotic features of electroencephalogram have been analyzed in various disease states like epilepsy, Alzheimer’s disease, sleep disorders, and depression. …”
Get full text
Article -
606
Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function
Published 2016-01-01“…The mitochondrial cascade hypothesis of dementia assumes mitochondrial dysfunction leading to reduced energy supply, impaired neuroplasticity, and finally cell death as one major pathomechanism underlying the continuum from brain aging over mild cognitive impairment to initial and advanced late onset Alzheimer’s disease. Accordingly, improving mitochondrial function has become an important strategy to treat the early stages of this continuum. …”
Get full text
Article -
607
Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
Published 2016-01-01“…Novel approaches using various types of stem cells have been proposed to treat common neurodegenerative disorders such as Alzheimer’s Disease, Parkinson’s Disease, or stroke. …”
Get full text
Article -
608
Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins
Published 2020-01-01“…In recent years, compelling evidence has shown that impairment of resolution of inflammation is a crucial pathogenic hallmark in different neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease. This review summarizes current knowledge on the role of resolvins in resolution of inflammation and highlights available evidence showing the neuroprotective potential of EPA- and DHA-derived resolvins (E-series and D-series resolvins, respectively) in neurodegenerative diseases.…”
Get full text
Article -
609
Complex Brain Network Analysis and Its Applications to Brain Disorders: A Survey
Published 2017-01-01“…It is well known that most brain disorders are complex diseases, such as Alzheimer’s disease (AD) and schizophrenia (SCZ). In general, brain regions and their interactions can be modeled as complex brain network, which describe highly efficient information transmission in a brain. …”
Get full text
Article -
610
Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives
Published 2016-01-01“…The management of neurodegenerative diseases such as Alzheimer’s disease (AD) and other dementias, Parkinson’s disease (PD) and PD related disorders, motor neuron diseases (MND), Huntington’s disease (HD), spinocerebellar ataxia (SCA), and spinal muscular atrophy (SMA), is mainly addressed to motor and cognitive impairment, with special care to vital functions as breathing and feeding. …”
Get full text
Article -
611
The role of structural viscoelasticity in deformable porous media with incompressibleconstituents: Applications in biomechanics
Published 2018-07-01“…Interestingly, the loss of viscoelastic tissue properties has been associated with various disease conditions, such as atherosclerosis, Alzheimer’s disease and glaucoma. Thus, the findings of this work may be relevant to many applications in biology and medicine.…”
Get full text
Article -
612
Association of a BACE1 Gene Polymorphism with Parkinson’s Disease in a Norwegian Population
Published 2015-01-01“…Parkinson’s disease (PD) and Alzheimer’s disease (AD) share pathological features, including amyloid-beta pathology. …”
Get full text
Article -
613
A hypothesis about interrelations of epigenetic factors and transposable elements in memory formation
Published 2024-09-01“…Analysis of the scientific literature allowed us to identify changes in the expression of 40 microRNAs derived from transposons in Alzheimer’s disease. For 24 of these microRNAs, the mechanisms of regulation of genes involved in the functioning of the brain have been described. …”
Get full text
Article -
614
Mechanisms and Emerging Regulators of Neuroinflammation: Exploring New Therapeutic Strategies for Neurological Disorders
Published 2024-12-01“…While acute neuroinflammation plays a protective role by facilitating pathogen clearance and tissue repair, chronic and dysregulated inflammation contributes significantly to the progression of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and Multiple Sclerosis. …”
Get full text
Article -
615
A bibliometric analysis of research on dementia comorbid with depression from 2005 to 2024
Published 2025-02-01“…The University of Toronto and the Journal of Alzheimer’s Disease were identified as key contributors to this field. …”
Get full text
Article -
616
A Corticobasal Syndrome Variant of Familial Creutzfeldt-Jakob Disease with Stroke-Like Onset
Published 2016-01-01“…Various neurodegenerative disorders are manifested with CBS as a clinical phenotype, including corticobasal degeneration (CBD), progressive supranuclear palsy, Alzheimer’s disease, and CJD. In our patient, mutation E200K and M129M polymorphism of the PRNP gene and typical immunohistochemical findings pointed to a diagnosis of CJD. …”
Get full text
Article -
617
Peripheral proteinopathy in neurodegenerative diseases
Published 2025-01-01“…Abstract Proteinopathies in neurology typically refer to pathological changes in proteins associated with neurological diseases, such as the aggregation of amyloid β and Tau in Alzheimer’s disease, α-synuclein in Parkinson’s disease and multiple system atrophy, and TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal dementia. …”
Get full text
Article -
618
Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations
Published 2013-01-01“…In Alzheimer’s disease (AD), tau aggregates into fibrils and higher order neurofibrillary tangles, a key histopathological feature of AD. …”
Get full text
Article -
619
Acute β-N-Methylamino-L-alanine Toxicity in a Mouse Model
Published 2015-01-01“…Long-term exposure to L-BMAA is believed to lead to neurodegenerative diseases including Parkinson’s and Alzheimer’s diseases and amyotrophic lateral sclerosis (Lou Gehrig’s disease). …”
Get full text
Article -
620
Acquired Localized Hypertrichosis Induced by Rivastigmine
Published 2016-01-01“…We report on a Caucasian 80-year-old male with personal history of Alzheimer’s disease. The patient started therapy with oral rivastigmine one month prior to clinical presentation of localized hypertrichosis on both forearms. …”
Get full text
Article